Paolo Paoletti

Board Member at Genmab

Extensive experience in research, development and commercialization in the pharmaceutical industry. Successfully conducted submissions and approvals of new cancer drugs and new indications in the USA and in Europe. Responsible for seven new medicines for cancer patients during his 10 years at GlaxoSmithKline and one new cancer medicine during his time at Eli Lilly.

Org chart

Anders Gersel Pedersen

Board Member

Rolf Hoffmann

Board Member

Mijke Zachariasse

Board Member

Pernille Erenbjerg

Deputy Chair

Deirdre P. Connelly

Chair

Martin Schultz

Board Member

Elizabeth O’Farrell

Board Member

Takahiro Hamatani

Board Member

Teams

+6

Board of Directors

9 members

Timeline

  • Board Member

    Current role